Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.88 |
| ▸ | MAPT | P10636 | 5/20 | 0.88 |
| ▸ | HTT | P42858 | 2/20 | 0.72 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.72 |
| ▸ | NPC1 | O15118 | 6/20 | 0.71 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.71 |
| ▸ | NR4A1 | P22736 | 1/20 | 0.70 |
| ▸ | NR4A2 | P43354 | 1/20 | 0.70 |
| ▸ | NR4A3 | Q92570 | 1/20 | 0.70 |
| ▸ | RAB9A | P51151 | 5/20 | 0.68 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.68 |
| ▸ | MAOB | P27338 | 1/20 | 0.66 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.65 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.65 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.65 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.65 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.64 |
| ▸ | CASP3 | P42574 | 1/20 | 0.63 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.63 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28761131 | 0.86 | ALDH1A1 (0.66) | ALDH1A1MAPTHTTMAPK1NPC1 | |
| SCHEMBL5971699 | 0.85 | NR4A1 (0.68) | ALDH1A1MAPTMAPK1NPC1PARP10 | |
| SCHEMBL16015339 | 0.85 | MEN1 (0.71) | ALDH1A1MAPTHTTMAPK1NPC1 | |
| SCHEMBL31148956 | 0.85 | ALDH1A1 (0.69) | ALDH1A1MAPTHTTMAPK1NPC1 | |
| SCHEMBL1056460 | 0.85 | MRGPRX4 (0.74) | ALDH1A1MAPTNPC1PARP10NR4A1 | |
| SCHEMBL28255418 | 0.85 | NR4A1 (0.68) | ALDH1A1MAPTNPC1PARP10NR4A1 | |
| SCHEMBL14924487 | 0.84 | MAPT (1.00) | ALDH1A1MAPTHTTMAPK1NPC1 | |
| SCHEMBL22192264 | 0.84 | RAB9A (0.94) | MAPTNPC1NR4A1NR4A2NR4A3 | |
| SCHEMBL28593279 | 0.84 | MAPT (0.73) | ALDH1A1MAPTHTTMAPK1NPC1 | |
| SCHEMBL28597324 | 0.84 | MEN1 (0.65) | ALDH1A1MAPTHTTMAPK1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 60 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122080895-A | Polyglycolic acid composition and preparation method thereof, biodegradable polyester material and application thereof, and PGA temporary plugging ball and preparation method thereof | — | 2026-05-26 | — | — | CN | claimed |
| WO-2025020685-A1 | PEROVSKITE THIN FILM LAYER AND PREPARATION METHOD THEREFOR, AND PEROVSKITE SILICON STACKED SOLAR CELL AND PREPARATION METHOD THEREFOR | 通威太阳能（成都）有限公司 | 2025-01-30 | — | — | WO | claimed |
| CN-116887609-A | Perovskite thin film layer and preparation method thereof, perovskite silicon laminated solar cell and preparation method thereof | 通威太阳能（成都）有限公司 | 2023-10-13 | — | — | CN | claimed |
| CN-107236106-A | The aromatic series terminal hydroxy group chain extender of the key containing acylhydrazone, selfreparing polyurethane and preparation method thereof | 青岛科技大学 | 2017-10-10 | — | — | CN | claimed |
| EP-0502110-B1 | (HETERO) 4-ARYLMETHOXY PHENYL DIAZOLE DERIVATIVES, METHOD FOR PREPARING SAME, AND THEIR THERAPEUTICAL APPLICATIONS | SYNTHELABO (FR) | 1995-02-01 | — | — | EP | claimed |
| WO-2025020685-A1 | PEROVSKITE THIN FILM LAYER AND PREPARATION METHOD THEREFOR, AND PEROVSKITE SILICON STACKED SOLAR CELL AND PREPARATION METHOD THEREFOR | 通威太阳能（成都）有限公司 | 2025-01-30 | — | — | WO | disclosed |
| CN-113166114-B | Cyclic tetramer compounds as inhibitors of proprotein convertase subtilisin/KEXIN type 9 (PCSK 9) for the treatment of metabolic disorders | 诺华股份有限公司 | 2025-01-03 | — | — | CN | disclosed |
| CN-118307534-A | LTA4H inhibitors and uses thereof | 上海海雁医药科技有限公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-116730941-B | 5-Phenyl-1, 3, 4-oxadiazole compound and preparation method and application thereof | 广东省科学院微生物研究所(广东省微生物分析检测中心) | 2024-07-02 | — | — | CN | disclosed |
| US-11813306-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | NOVARTIS AG (CH) | 2023-11-14 | — | — | US | disclosed |
| US-11813306-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | NOVARTIS AG (CH) | 2023-11-14 | — | — | US | disclosed |
| US-11813306-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | NOVARTIS AG (CH) | 2023-11-14 | — | — | US | disclosed |
| US-6069153-A | HORMONE REPLACEMENT THERPAY | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-05-30 | — | — | US | disclosed |
| WO-1999058524-A1 | BENZOCARBAZOLE AND INDENOINDOLE DERIVED ESTROGENIC AGENTS | AMERICAN HOME PRODUCTS CORPORATION (US) | 1999-11-18 | — | — | WO | disclosed |
| EP-0562824-B1 | Thermal recording material | FUJI PHOTO FILM CO LTD (JP) | 1997-06-11 | — | — | EP | disclosed |
| US-5464804-A | Heat sensitive color layer with electron donor, colorless dye is black color aminofluoran, amino compound and isocyanate compound | FUJI PHOTO FILM CO., LTD. (JP) | 1995-11-07 | — | — | US | disclosed |
| US-5288688-A | Comprising electron-donating colorless dye, isocyanate and amino compounds; antifogging, discoloration inhibition, storage stability | FUJI PHOTO FILM CO., LTD. (JP) | 1994-02-22 | — | — | US | disclosed |
| US-5250551-A | Monoamine oxidase inhibitors | DELALANDE S.A. (FR) | 1993-10-05 | — | — | US | disclosed |
| EP-0562824-A2 | Thermal recording material | FUJI PHOTO FILM CO., LTD. (JP) | 1993-09-29 | — | — | EP | disclosed |
| US-5100910-A | Monoamine Oxidase Inhibitors | DELALANDE S.A. (FR) | 1992-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11813306-B2 | Cyclic tetramer compounds as proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors for the treatment of metabolic disorders | PCSK9, PCSK7, PCSK6 | ALDH1A1 4739/4885MAPT 114/4885HTT 548/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.